Social networks
2,703Activities
Technologies
Entity types
Location
Hälsovägen 7, 141 57 Huddinge, Sweden
Flemingsberg
Sweden
Employees
Scale: 11-50
Estimated: 22
Engaged corporates
2Added in Motherbase
9 months, 1 week agoINDIVIDUALIZED NK CELL THERAPIES
XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and solid tumors. The most advanced product candidate, evencaleucel, is being evaluated in a phase II clinical study in combination with the CD38 monoclonal antibody, isatuximab, as consolidation therapy following stem cell transplantation in newly diagnosed multiple myeloma patients. At the core of XNK is a committed and experienced team that includes world-renowned NK cell experts and pioneers in the field. The company has developed a proprietary technology platform of broad utility and benefits from its tailor-made GMP facility and co-location with the Karolinska Institute and the Karolinska University Hospital. XNK is well positioned to bring transformational autologous NK cell-based therapies and new hope to cancer patients around the world.
Immunotherapy, Autologous Cell Therapy, Biotechnology, Cellular Therapeutics, NK Cell Therapy, Biotechnology, Oncology, Cell Therapy, and Biopharmaceutical
XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Vinnova Government Administration | Vinnova Government Administration | Other 29 Jan 2024 | | |
Business Sweden Business Consulting and Services | Business Sweden Business Consulting and Services | Other 29 Jan 2024 | |